Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Desert plant may help treat insidious tropical diseases

17.03.2005


Plants native to the Mojave Desert may one day help provide relief to millions of people who suffer from two prominent tropical diseases.


Image of dotted dalea (Psorothamnus polydenius). Source: http://ww1.clunet.edu/wf/



Scientists at Ohio State University found that extracts of the dotted dalea (Psorothamnus polydenius) and the Mojave dalea (Psorothamnus arborescens) can kill the parasites, which are a kind of protozoa that cause the diseases leishmaniasis and African sleeping sickness. While both diseases are rare in North America, they are prevalent in dozens of countries worldwide, particularly developing nations. If left untreated, the diseases can be fatal.

The drugs currently used to treat both illnesses are costly and some are toxic, said Karl Werbovetz, a study co-author and an assistant professor of medicinal chemistry and pharmacognosy at Ohio State. Also, the chance of these parasites developing resistance to these medications is increasing.


"Most of the available drugs are given by injection over a long course of time," Werbovetz said. "We’re hoping to develop those extracts into effective compounds that are cheap and readily available, and that can be taken by mouth."

Werbovetz conducted the study with Manar Salem, a doctoral candidate in medicinal chemistry and pharmacognosy. The two presented their findings on P. arborescens on March 16 in San Diego at the national meeting of the American Chemical Society. Their findings on P. polydenius appear in a recent issue of the Journal of Natural Products.

The researchers first screened hundreds of plant extracts to see which, if any, would kill Leishmania donovani and Trypanosoma brucei, the parasitic protozoa that cause leishmaniasis and African sleeping sickness, respectively. Leishmaniasis is transmitted by sand flies, while African sleeping sickness, or African trypanosomiasis, is transmitted by the tsetse fly.

The researchers conducted laboratory tests to determine which plant extracts would kill the protozoa but not harm healthy kidney cells cultured from the African Green Monkey.

Extracts from these related plants were among the best inhibitors of parasite growth while showing lesser effects on the kidney cells.

While there are several forms of leishmaniasis, the most common forms affect the surface of the skin (cutaneous leishmaniasis) or the internal organs (visceral leishmaniasis). Cutaneous leishmaniasis causes open sores and raised boils on the skin, while visceral leishmaniasis invades the liver and spleen and causes these organs to swell. People with the visceral form of the disease develop anemia and also lose a significant amount of weight. Visceral leishmaniasis is fatal in 90 percent of all cases left untreated.

About 2 million new cases of leishmaniasis are reported each year, according to the World Health Organization (WHO). Of those, at least half a million are visceral leishmaniasis. The disease is found in Mexico, Central and South America, Southern Europe, Asia, the Middle East, and Africa.

Also, several hundred U.S. soldiers stationed in the Middle East have developed cutaneous leishmaniasis.

"At last count, about 700 of our soldiers had the disease," Werbovetz said. "It’s not an illness that people die from, and the troops can still perform their duties. But it does leave scars and can also make a person prone to infection."

Sleeping sickness affects people in mostly rural areas of sub-Saharan Africa. The disease usually begins with a high fever, a rash and swollen glands and, if left untreated, can progress into the brain, where it causes inflammation, coma and, eventually, death.

"The primary drug used to treat African sleeping sickness kills 5 percent of the people who take it arsenic is one of its main ingredients," Werbovetz continued. "But left untreated, the disease kills 100 percent of those infected."

However, not only are the drugs used to treat African sleeping sickness expensive, they’re not available everywhere they are needed.

According to the WHO, African sleeping sickness threatens over 60 million people in 36 countries of sub-Saharan Africa. Estimates on how many people develop the disease annually vary anywhere from 50,000 to 500,000, Werbovetz said.

"Real estimates are virtually impossible to come up with because of the rural nature of this disease," he said.

Karl Werbovetz | EurekAlert!
Further information:
http://www.osu.edu

More articles from Life Sciences:

nachricht Unique genome architectures after fertilisation in single-cell embryos
30.03.2017 | IMBA - Institut für Molekulare Biotechnologie der Österreichischen Akademie der Wissenschaften GmbH

nachricht Transport of molecular motors into cilia
28.03.2017 | Aarhus University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Challenging European Research Project to Develop New Tiny Microscopes

The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.

To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

'On-off switch' brings researchers a step closer to potential HIV vaccine

30.03.2017 | Health and Medicine

Penn studies find promise for innovations in liquid biopsies

30.03.2017 | Health and Medicine

An LED-based device for imaging radiation induced skin damage

30.03.2017 | Medical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>